American Journal of Psychiatry · 1995 · 230 citations · 6 references
MedicinePharmacologyPsychiatryClinical PharmacologyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepressionDepression PharmacotherapyDepressive DisordersAntidepressant MedicationsAntidepressant ResponseDepression Placebo ResponseDouble-blind TrialsMechanisms Of Antidepressant Action
OBJECTIVE: CSF levels of inositol have been reported to be lower than normal in depressed subjects. The authors administered inositol to depressed patients in a double-blind, controlled trial. METHOD: Under double-blind conditions, 12 g/day of inositol (N = 13) or placebo (N = 15) was administered to depressed patients for 4 weeks. RESULTS: The overall improvement in scores on the Hamilton Depression Rating Scale was significantly greater for inositol than for placebo at week 4. No changes were noted in hematology or in kidney or liver function. CONCLUSIONS: This may be the first use of the precursor strategy for a second messenger rather than a neurotransmitter in treating depression. Although inositol had a significant antidepressant effect in this study, replication is crucial.
6
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder.
Barkai Ai, Dunner Dl, Gross Ha et al. · PubMed · 1978 · 108 citations
Inositol treatment raises CSF inositol levels
Jay F. Levine, Alain Rapaport, Louise Lev et al. · Brain Research · 1993 · 65 citations